Nuclear medicine firm Digirad has received the CE Mark for its Cardius X-ACT imaging system in Europe.
Cardius X-ACT is a cardiac SPECT/volume computed tomography (VCT) imaging scanner that features a low-dose VCT attenuation correction system designed to reduce imaging artifacts caused by overlying tissues. X-ACT offers a 24-inch-wide (63.5-cm) detector array and triple-head solid-state digital detectors.
Digirad previously received clearance from the U.S. Food and Drug Administration to market the Cardius X-ACT imaging system in the U.S.
